Citigroup’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.17M Sell
34,324
-51,882
-60% -$3.28M ﹤0.01% 1971
2025
Q1
$4.57M Buy
86,206
+16,429
+24% +$870K ﹤0.01% 1469
2024
Q4
$3.91M Buy
69,777
+28,580
+69% +$1.6M ﹤0.01% 1622
2024
Q3
$2.16M Buy
41,197
+21,205
+106% +$1.11M ﹤0.01% 1982
2024
Q2
$821K Sell
19,992
-170,528
-90% -$7M ﹤0.01% 2387
2024
Q1
$8.26M Buy
190,520
+136,220
+251% +$5.9M 0.01% 973
2023
Q4
$2.5M Sell
54,300
-14,844
-21% -$682K ﹤0.01% 1493
2023
Q3
$1.59M Sell
69,144
-18,921
-21% -$434K ﹤0.01% 1612
2023
Q2
$1.45M Sell
88,065
-251,890
-74% -$4.15M ﹤0.01% 1957
2023
Q1
$6.06M Buy
339,955
+64,394
+23% +$1.15M ﹤0.01% 1034
2022
Q4
$8.02M Buy
275,561
+3,374
+1% +$98.3K 0.01% 883
2022
Q3
$6.67M Buy
272,187
+269,921
+11,912% +$6.61M ﹤0.01% 976
2022
Q2
$9K Sell
2,266
-2,266
-50% -$9K ﹤0.01% 4668
2022
Q1
$52K Sell
4,532
-91,485
-95% -$1.05M ﹤0.01% 4016
2021
Q4
$958K Buy
96,017
+36,291
+61% +$362K ﹤0.01% 2602
2021
Q3
$780K Sell
59,726
-72,173
-55% -$943K ﹤0.01% 2579
2021
Q2
$2.58M Sell
131,899
-20,529
-13% -$402K ﹤0.01% 1912
2021
Q1
$3.24M Buy
152,428
+143,603
+1,627% +$3.05M ﹤0.01% 1630
2020
Q4
$262K Buy
8,825
+1,429
+19% +$42.4K ﹤0.01% 3070
2020
Q3
$160K Sell
7,396
-15,938
-68% -$345K ﹤0.01% 2887
2020
Q2
$520K Buy
23,334
+3,299
+16% +$73.5K ﹤0.01% 2539
2020
Q1
$305K Buy
20,035
+5,585
+39% +$85K ﹤0.01% 2600
2019
Q4
$332K Sell
14,450
-1,587
-10% -$36.5K ﹤0.01% 2870
2019
Q3
$347K Sell
16,037
-8,809
-35% -$191K ﹤0.01% 2775
2019
Q2
$547K Buy
24,846
+21,550
+654% +$474K ﹤0.01% 2604
2019
Q1
$91K Sell
3,296
-64,607
-95% -$1.78M ﹤0.01% 3648
2018
Q4
$1.83M Buy
67,903
+40,469
+148% +$1.09M ﹤0.01% 1590
2018
Q3
$801K Buy
27,434
+25,678
+1,462% +$750K ﹤0.01% 2166
2018
Q2
$55K Buy
1,756
+715
+69% +$22.4K ﹤0.01% 3814
2018
Q1
$21K Buy
1,041
+113
+12% +$2.28K ﹤0.01% 4200
2017
Q4
$27K Buy
+928
New +$27K ﹤0.01% 4114